FINWIRES · TerminalLIVE
FINWIRES

North American Construction Group Expands Key Contract in Queensland Australia

-- North American Construction Group (NOA.TO) on Tuesday announced that its wholly owned subsidiary MacKellar Group has amended and expanded an existing five-year contract with a "leading" metallurgical coal producer in the state of Queensland, Australia.

The company said that the previous contract, announced in August 2024, had transitioned equipment under contract from dry rental to fully maintained fleets and awarded the construction of an on-site maintenance facility.

The company further said that the amended and expanded five-year contract maintains the expiry date of Sept. 30, 2029 and continues to qualify as contractual backlog based on minimum hour commitments in the agreement.

In a statement the company noted that the expanded scope, which includes additional fully maintained equipment and related services, is expected to generate approximately $125 million of incremental revenue and increases MacKellar's scope at that mine site by approximately 50%. The expanded contract is consistent with the financial outlook previously contemplated in the company's full year 2026 guidance, it said.

It added that the expanded scope is set to commence May 1, 2026 and reach full run rate by August 2026.

"Of the thirteen additional units supporting this growth, eight Komatsu 240-ton haul trucks were already purchased in December 2025 and publicly announced as part of the Company's fleet optimization initiatives, reflecting NACG's early positioning for this expected customer demand," said the company. The company added the remaining five units are expected to be acquired as growth capital during the second and third quarters of 2026 at an estimated cost of approximately $25 million.

It is not clear if the figures are in Canadian dollars, which is what the company reports its financials in.

"This contract expansion reflects the confidence our customer continues to place in our team and MacKellar's strong operating performance," said Barry Palmer, Chief Executive Officer of NACG. "It adds meaningful revenue visibility and contractual backlog, while also highlighting the disciplined way we deploy capital against identifiable demand. With MacKellar and Iron Mine Contracting, we continue to strengthen our Tier 1 contractor platform in Australia and enhance our ability to capture additional opportunities across the region."

Shares in NOA were down $0.56 or near 3% at $18.63 in Canada yesterday.

Related Articles

Australia

Top Cryptocurrencies Fall; Bitcoin Falls Below $75,000

Top cryptocurrencies fell Tuesday, with Bitcoin (BTC-USD) dropping below the $75,000 level.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, fell almost 0.6% in the past 24 hours. The Nasdaq 100 fell 0.5%, the S&P 500 and the Dow Jones Industrial Average were down about 0.6% each.Bitcoin dropped 1.7% to $74,985, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume fell 7.1% to $37.1 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, dipped 1.4% to $2,297.XRP (XRP-USD) declined 1%, BNB (BNB-USD) fell 0.7%, and Solana (SOL-USD) shed 1.6%. Dogecoin (DOGE-USD) dropped 1.6%, and Cardano (ADA-USD) lost 1.6%.The US 10-year Treasury yield stood at 4.289% at 3 p.m. ET Tuesday, up from 4.248% Monday, while the five-year yield rose to 3.906% from 3.848%.The total market value of the cryptocurrency industry fell 0.6% in the past 24 hours to $2.55 trillion, with trading volume declining 1.5% to $153.37 billion.Price: $74991.13, Change: $-863.67, Percent Change: -1.14%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Sectors

Sector Update: Financial Stocks Retreat Late Afternoon

Financial stocks were declining in late Tuesday afternoon trading, with the NYSE Financial Index decreasing 0.6% and the State Street Financial Select Sector SPDR ETF (XLF) off by 0.3%.The Philadelphia Housing Index was adding 0.8%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) fell 1.6%.Bitcoin (BTC-USD) was decreasing 0.2% to $75,717, and the yield for 10-year US Treasuries rose 4.2 basis points to 4.29%.In economic news, US retail sales rose 1.7% in March, above the 1.4% increase expected in a Bloomberg-compiled survey and following the previous month's revised 0.7% gain. Removing both motor vehicles and a 15.5% surge in gasoline station sales, retail sales were up 0.6% in March, the same as in February.US pending home sales increased more than expected in March despite higher mortgage rates, data from the National Association of Realtors showed.In corporate news, JPMorgan Chase (JPM) is working to secure approval from securities regulators in China to launch actively managed exchange-traded funds in the country for the first time, Bloomberg reported. JPMorgan shares were down 1.3%.Coinbase (COIN) and Gemini Titan have been sued by New York Attorney General Letitia James for allegedly violating the state laws against illegal gambling with their prediction markets, Reuters reported, citing complaints filed in a state court in Manhattan. Coinbase shares fell past 7%.Washington Trust Bancorp (WASH) reported late Monday a year-over-year decline in Q1 revenue that also trailed analysts' estimates. Its shares tumbled nearly 17%.Barclays (BCS) is facing scrutiny from UK regulators over its use of significant risk transfer, or SRT, transactions, Bloomberg reported. The review, known as a Section 166 probe, has been requested by the Prudential Regulation Authority, the supervisory arm of the Bank of England, the report said. Barclays shares fell 2.9%.

$BCS$COIN$JPM$WASH
Sectors

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index down 1% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.9%.The iShares Biotechnology ETF (IBB) decreased 1%.In corporate news, Passage Bio (PASG) faces a tougher path after US regulators told the company it will need to run a randomized study to support approval of its experimental treatment PBFT02, a move that adds time, cost, and uncertainty, Wedbush said Tuesday in a report. Wedbush downgraded Passage Bio's stock to neutral from outperform and cut its price target to $8 from $32. Passage Bio shares dropped 2.9%.Merck (MRK) and Japanese health care company Eisai said Tuesday that phase 3 trials of two drug combinations failed to meet primary endpoints of progression-free survival and overall survival as a first-line treatment of patients with advanced clear cell renal cell carcinoma compared with Keytruda plus Lenvima. Merck shares fell 3.7%.UnitedHealth Group (UNH) raised its full-year earnings outlook on Tuesday as the health insurance giant recorded an unexpected annual increase in its first-quarter results. Its shares jumped past 7%.Quest Diagnostics (DGX) shares popped more than 4% after it reported higher Q1 adjusted earnings and net revenue and raised its 2026 outlook.

$DGX$MRK$PASG$UNH